Title: Cardiology Grand Rounds: Lessons Learned from DOAC's and the New Factor XI Anti-thrombotic Therapies Being Studied

Speaker: Manesh R. Patel, MD

Chief, Division of Cardiology

Co-Director, Duke Heart Center

Duke Clinical Research Institute

Duke University, Durham, NC

Disclosures:

Research Grants: PACIFIC-AF: Bayer, Janssen, Heartflow, Idorsia, NHLBI, Novartis

Advisory Board/Consulting: Bayer, Janssen, Heartflow, Medscape

Objectives:

•Understand the Net-Benefit of Warfarin and then NOACs in AFib

•Understand the use of NOACs and limitations

•Understand the Factor XI therapy and promise in A. Fib